日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial

罗莫索珠单抗治疗绝经后骨质疏松症3个月与12个月的疗效比较(LIDA):一项开放标签、非劣效性、随机对照试验

Leder, Benjamin Z; Ramchand, Sabashini K; Jordan, Mackenzie; Ryan, Savannah; Patnaik, Aparna; Lee, Hang; Tsai, Joy N

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study

奥洛莫拉西布(一种新一代 KRAS G12C 抑制剂)在 KRAS G12C 突变型晚期实体瘤中的泛肿瘤活性:一项首次人体研究

Murciano-Goroff, Yonina R; Hollebecque, Antoine; Heist, Rebecca S; Cassier, Philippe A; Han, Ji-Youn; Kim, So Yeon; Sabari, Joshua K; Tosi, Diego; Sacher, Adrian; Burns, Timothy F; Shimizu, Toshio; Reddy Ammakkanavar, Natraj; Spira, Alexander; Gomez-Roca, Carlos; Patnaik, Amita; Cosman, Rasha; Bodor, J Nicholas; Nagasaka, Misako; You, Arthur Xintian; McNeely, Samuel C; Peter, Raimund; Fink, Aaron; Chen, Aaron; Oxnard, Geoffrey R; Willard, Melinda D; Kuboki, Yasutoshi; Koyama, Takafumi

T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responses.

T 细胞固有的 VISTA 表达通过限制 CD8+ T 细胞反应来促进对 CTLA-4 阻断的抵抗。

Gilmour Cassandra, DeLaney Elizabeth, Parthasarathy Prerana B, Roy Dia, Ta Hieu M, Zakeri Amin, Elguera Grandez Paolo, Patnaik Sachin, Zhang Keman, Juric Ivan, Rangan Rahul, Al-Hilli Zahraa, Tufaro Anthony, Min Booki, Weinberg Samuel E, Chan Timothy A, Silver Natalie L, Avril Stefanie, Alban Tyler, Wang Li Lily

One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol

慢性粒单核细胞白血病中TET2基因突变数量(1个、2个或≥3个):共突变模式及其在包括BLAST-mol和CPSS-mol在内的现代预后模型中的预后意义

Yousuf, Muhammad; Fathima, Saubia; Alsugair, Ali Khalid A; Wu, Samuel J; Abdelmagid, Maymona G; Patel, Shraddha P; Faldu, Priyansh C; Abdelaziz, Rania M; Csizmar, Clifford M; Mangaonkar, Abhishek A; Zepeda Mendoza, Cinthya J; Reichard, Kaaren K; Viswanatha, David S; He, Rong; Pardanani, Animesh; Gangat, Naseema; Patnaik, Mrinal S; Tefferi, Ayalew

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断和治疗的指导声明,由国际VEXAS工作组专家组制定

Mekinian, Arsene; Georgin-Lavialle, Sophie; Ferrada, Marcela A; Savic, Sinisa; Koster, Matthew J; Kosmider, Olivier; Comont, Thibault; Heiblig, Mael; Arostegui, Juan I; Bosco, Annmarie; Bourguiba, Rim; Calvo, Katherine R; Cargo, Catherine; Cattaneo, Chiara; Chasset, François; Coelho, Henrique; Campochiaro, Corrado; Crisafulli, Francesca; Ducharme-Benard, Stephanie; Faria, Raquel; Franceschini, Franco; Frassi, Micol; Groarke, Emma M; Gurnari, Carmelo; Hakobyan, Yervand; Jamilloux, Yvan; Jurcut, Ciprian; Kirino, Yohei; Kulasekararaj, Austin; Kunimoto, Hiroyoshi; Madigan, Lauren M; Mann, Heřman F; Marvisi, Chiara; Milchert, Marcin; Morais, Sara; Sockel, Katja; Muratore, Francesco; Nakajima, Hideaki; Patnaik, Mrinal M; Regadas, Luísa; Robin, Marie; Rutgers, Abraham; Salvarani, Carlo; Sammel, Anthony M; Seebach, Joerg; Sujobert, Pierre; Tomelleri, Alessandro; Urbanski, Geoffrey; Vandergheynst, Frédéric; Vieira, Romana; Viswanatha, David S; Więsik-Szewczyk, Ewa; Diral, Elisa; Terrier, Benjamin; Patel, Bhavisha A; Fenaux, Pierre; Grayson, Peter C; Beck, David B

Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

整合单细胞分析揭示了与实体瘤免疫抑制相关的二分性NK细胞群。

Lozada John R, Ali Atef, Luo Christine, Plagens Rosemary N, Zhang Bin, Elliott Andrew, Boytim Ella, Zorko Nicholas A, Heath Elisabeth I, Patnaik Akash, VanderWalde Ari M, Antonarakis Emmanuel S, Miller Jeffrey S, Hwang Justin H, Cichocki Frank

Diagnosis and management of adult telomere biology disorders

成人端粒生物学疾病的诊断和治疗

Franke, Madeline; Ferrer, Alejandro; Patnaik, Mrinal M

A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns

慢性粒单核细胞白血病一线治疗策略的回顾性分析:对生存率和反应模式的影响

Yousuf, Muhammad; Faldu, Priyansh; Abdelmagid, Maymona; Aperna, Fnu; Fathima, Saubia; Alsugair, Ali Khalid A; Csizmar, Clifford M; Lasho, Terra L; Mangaonkar, Abhishek A; Reichard, Kaaren K; He, Rong; Pardanani, Animesh; Gangat, Naseema; Patnaik, Mrinal M; Tefferi, Ayalew

Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment

未接受治疗的新诊断急性髓系白血病患者的特征

Alkabbani, Oudai; Jabban, Yazan; He, Rong; Viswanatha, David; Bessonen, Kurt; Greipp, Patricia; Jevremovic, Dragan; Foran, James M; Badar, Talha; Yi, Cecilia Arana; Kusne, Yael; Saliba, Antoine N; Hefazi, Mehrdad; Matin, Aasiya; Hogan, William J; Mangaonkar, Abhishek; Alkhateeb, Hassan; Patnaik, Mrinal; Shah, Mithun; Begna, Kebede; Litzow, Mark R; Al-Kali, Aref

Azacitidine for MDS and CMML

阿扎胞苷用于治疗骨髓增生异常综合征 (MDS) 和慢性粒单核细胞白血病 (CMML)。

Martin, Emma St; Patnaik, Mrinal M